Lung Screening Uptake Lags in Newly ACS-Eligible Former Smokers

A cross-sectional analysis of 2024 National Health Interview Survey data compared lung cancer screening uptake between adults eligible under 2021 USPSTF criteria and those newly eligible only under the expanded 2023 American Cancer Society guideline, which removed the 15-year smoking cessation cutoff. Past-12-month screening prevalence was 17.8% among USPSTF-eligible adults versus 8.0% among ACS-only-eligible adults, with USPSTF eligibility showing stronger associations with both past-year and any reported screening than ACS-only eligibility. The authors state these findings suggest early implementation of the broader ACS criteria while highlighting a need for equity-focused, clinician- or system-triggered strategies to identify former smokers with a remote quit history.

Most relevant for: Former smokers with a remote (more than 15 years) quit history who meet expanded 2023 ACS lung cancer screening eligibility but not 2021 USPSTF criteria.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.